Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-25-105812
Filing Date
2025-08-08
Accepted
2025-08-08 16:05:49
Documents
79
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q clsd-20250630.htm   iXBRL 10-Q 1625810
2 EX-10.1 clsd-ex10_1.htm EX-10.1 166109
3 EX-10.2 clsd-ex10_2.htm EX-10.2 72861
4 EX-10.3 clsd-ex10_3.htm EX-10.3 175370
5 EX-10.4 clsd-ex10_4.htm EX-10.4 72634
6 EX-10.5 clsd-ex10_5.htm EX-10.5 175171
7 EX-10.6 clsd-ex10_6.htm EX-10.6 77376
8 EX-31.1 clsd-ex31_1.htm EX-31.1 15472
9 EX-31.2 clsd-ex31_2.htm EX-31.2 15188
10 EX-32.1 clsd-ex32_1.htm EX-32.1 10425
11 GRAPHIC img143325015_0.jpg GRAPHIC 369094
12 GRAPHIC img143325015_1.jpg GRAPHIC 183840
13 GRAPHIC img253154410_0.jpg GRAPHIC 3440
14 GRAPHIC img254077931_0.jpg GRAPHIC 3440
15 GRAPHIC img255001452_0.jpg GRAPHIC 3440
16 GRAPHIC img255924973_0.jpg GRAPHIC 3440
17 GRAPHIC img256848494_0.jpg GRAPHIC 3440
18 GRAPHIC img257772015_0.jpg GRAPHIC 3440
  Complete submission text file 0000950170-25-105812.txt   9024866

Data Files

Seq Description Document Type Size
19 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT clsd-20250630.xsd EX-101.SCH 1170629
81 EXTRACTED XBRL INSTANCE DOCUMENT clsd-20250630_htm.xml XML 977250
Mailing Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005
Business Address 900 NORTH POINT PARKWAY SUITE 200 ALPHARETTA GA 30005 678-270-3631
Clearside Biomedical, Inc. (Filer) CIK: 0001539029 (see all company filings)

EIN.: 452437375 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37783 | Film No.: 251198375
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)